Q3 2017 13F Holders as of 30 Sep 2017
-
Type / Class
-
Equity / COM NEW
-
Total 13F shares
-
19,733,662
-
Share change
-
+296,314
-
Total reported value
-
$175,258,470
-
Put/Call ratio
-
201%
-
Price per share
-
$8.88
-
Number of holders
-
107
-
Value change
-
+$93,421
-
Number of buys
-
56
-
Number of sells
-
42
Institutional Holders of INSYS THERAPEUTICS INC NEW - COM NEW (INSYQ) as of Q3 2017
As of 30 Sep 2017 INSYS THERAPEUTICS INC NEW - COM NEW (INSYQ) had 107 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 19,733,662 shares of stock of the company.
Largest 10 holders included ORBIMED ADVISORS LLC, BlackRock Inc., VANGUARD GROUP INC, Mirae Asset Global Investments Co., Ltd., NORGES BANK, Invesco Ltd., STATE STREET CORP, DIMENSIONAL FUND ADVISORS LP, Folger Hill Asset Management LP, and NORTHERN TRUST CORP.
This table shows 107 institutional shareholders of the security as of 30 Sep 2017.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.